ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 2 filers reported holding ONCOCYTE CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,777 | -9.9% | 16,422 | +38.8% | 0.00% | – |
| Q1 2023 | $4,193 | +4.4% | 11,830 | -5.5% | 0.00% | – |
| Q4 2022 | $4,017 | -55.4% | 12,519 | -0.0% | 0.00% | – |
| Q3 2022 | $9,000 | -35.7% | 12,523 | -17.3% | 0.00% | – |
| Q2 2022 | $14,000 | -22.2% | 15,151 | -1.6% | 0.00% | – |
| Q1 2022 | $18,000 | -33.3% | 15,397 | +22.1% | 0.00% | – |
| Q4 2021 | $27,000 | -41.3% | 12,612 | -2.3% | 0.00% | – |
| Q3 2021 | $46,000 | -36.1% | 12,913 | +2.5% | 0.00% | – |
| Q2 2021 | $72,000 | +4.3% | 12,598 | -5.6% | 0.00% | – |
| Q1 2021 | $69,000 | +64.3% | 13,349 | -22.6% | 0.00% | – |
| Q1 2020 | $42,000 | +250.0% | 17,248 | +197.3% | 0.00% | – |
| Q3 2019 | $12,000 | – | 5,802 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 14,716,204 | $20,456,000 | 1.61% |
| PURA VIDA INVESTMENTS, LLC | 6,022,534 | $8,371,000 | 0.43% |
| P.A.W. CAPITAL CORP | 199,700 | $278,000 | 0.30% |
| Penbrook Management LLC | 229,425 | $319,000 | 0.28% |
| PERKINS CAPITAL MANAGEMENT INC | 39,725 | $55,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 201,047 | $279,000 | 0.05% |
| Private Wealth Partners, LLC | 150,000 | $209,000 | 0.02% |
| Phoenix Holdings Ltd. | 317,138 | $426,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 255,300 | $355,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 157,933 | $226,000 | 0.01% |